Recent Material Events - Stemcells, Inc (STEM)

Filing Date	Description
2008-05-13	On May 12, 2008, the Company announced it has brought a second patent infringement suit against Neuralstem, Inc., including its founders. The Company filed the complaint in the U.S. Federal District Court in Northern California on May 7, 2008 and an ...
2008-03-21	Effective March 18, 2008, the Company and Progenitor Cell Therapy, LLC ("PCT") amended their existing note purchase agreement to accelerate the date for repayment of the outstanding principal, plus interest, by PCT to June 26, 2008 and to acknowledge ...
2008-03-05	On March 4, 2008, the Company announced it is no longer pursuing a possible acquisition of Progenitor Cell Therapy, LLC ("PCT"). The Company had announced on December 3, 2007 that it was exploring such an acquisition and that PCT had agreed to a peri ...
2007-12-04	On December 3, 2007, the Company entered into a note purchase agreement and security agreement with Progenitor Cell Therapy, LLC ("PCT"), a leading provider of cGMP-quality cell processing services headquartered in Hackensack, NJ. Pursuant to the not ...
2007-12-03	On November 30, 2007, StemCells, Inc. announced that the first patient to receive a transplant of HuCNS-SC cells (purified human neural stem cells) in the Company’s Phase I clinical trial has completed the trial. The patient, who was transplan ...
2007-02-28	On February 28, 2007, StemCells, Inc. issued a press release announcing its fourth quarter and year end financial results for the year ended December 31, 2006. The full text of the press release is attached hereto as Exhibit 99.1.... ...
2007-01-12	(d) On January 10, 2007, StemCells, Inc., (the “Company”) increased the size of its Board of Directors from six to seven and appointed Desmond H. O’Connell, Jr. to the Board of Directors as a Class II director with a term expiring at... ...
2006-12-29	On December 29, 2006, StemCells, Inc. (the “Company”) entered into a Sales Agreement (the “Agreement”) with Cantor Fitzgerald & Co. (“Cantor”) for the purpose of selling shares of the Company’s common stock in... ...
2006-12-06	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.... ...
2006-11-01	On November 1, 2006, StemCells, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2006. The full text of the press release is attached hereto as Exhibit 99.1.... ...